A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus
Status:
Not yet recruiting
Trial end date:
2023-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of thalidomide in the
treatment of refractory uremic pruritus in maintenance hemodialysis patients.